Literature DB >> 17921195

Colorectal cancer risk, chronic illnesses, operations and medications: case control results from the Melbourne Colorectal Cancer Study. 1988.

Gabriel A Kune1, Susan Kune, Lyndsey F Watson.   

Abstract

The associations between colorectal cancer risk and several chronic illnesses, operations and various medications were examined in 715 colorectal cancer cases and 727 age- and sex-matched controls in data derived from a large, comprehensive population-based study of this cancer conducted in Melbourne, Australia. There was a statistically significant deficit among cases of hypertension, heart disease, stroke, chronic chest disease and chronic arthritis and a statistically significant excess of 'haemorrhoids' among cases, and all of these differences were consistent for both colon and rectal cancers and for both males and females. Although no statistically significant differences were found for other cancers, there were twice as many breast cancers among cases (16) than among controls (8) and also there were 9 uterine cancers among cases and only 2 among controls. There was a statistically significant deficit among cases in the use of aspirin-containing medication and vitamin supplements and this was consistent for both colon and rectal cancers and for both males and females. There was a statistically significant excess of large bowel polypectomy among cases. The modelling of these significant associations simultaneously in a logistic regression equation indicated that hypertension, heart disease, chronic arthritis and aspirin use were each independent effects and consistent for both colon and rectal cancers for both males and females and also that these effects were independent of dietary risk factors previously described in the Melbourne study. The possible relevance of these findings towards an understanding of colorectal cancer risk and aetiology is discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17921195     DOI: 10.1093/ije/dym193

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  8 in total

1.  Is alexithymia related to colon cancer? A survey of patients undergoing a screening colonoscopy examination.

Authors:  M Lauriola; A Panno; M Tomai; V Ricciardi; A E Potenza
Journal:  J Clin Psychol Med Settings       Date:  2011-12

Review 2.  Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer?

Authors:  Hiroki Yuhara; Craig Steinmaus; Stephanie E Cohen; Douglas A Corley; Yoshihiro Tei; Patricia A Buffler
Journal:  Am J Gastroenterol       Date:  2011-09-13       Impact factor: 10.864

Review 3.  Mapping the protein-protein and genetic interactions of cancer to guide precision medicine.

Authors:  Mehdi Bouhaddou; Manon Eckhardt; Zun Zar Chi Naing; Minkyu Kim; Trey Ideker; Nevan J Krogan
Journal:  Curr Opin Genet Dev       Date:  2019-07-06       Impact factor: 5.578

4.  Stroke in cancer patients: a risk factor analysis.

Authors:  Oberndorfer Stefan; Nussgruber Vera; Berger Otto; Lahrmann Heinz; Grisold Wolfgang
Journal:  J Neurooncol       Date:  2009-03-12       Impact factor: 4.130

5.  Effect of diabetes mellitus on outcomes of colorectal cancer.

Authors:  Geum Youb Noh; Dae-Yong Hwang; Yoon Hee Choi; Yun Yong Lee
Journal:  J Korean Soc Coloproctol       Date:  2010-12-31

6.  Inverse association of colorectal cancer prevalence to serum levels of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in a large Appalachian population.

Authors:  Kim E Innes; Jeffrey H Wimsatt; Stephanie Frisbee; Alan M Ducatman
Journal:  BMC Cancer       Date:  2014-01-27       Impact factor: 4.430

7.  In Vitro Cytotoxic Effects of Celecoxib, Mefenamic Acid, Aspirin and Indometacin on Several Cells Lines.

Authors:  Maryam Alsadat Hashemipour; Hoda Mehrabizadeh Honarmand; Farideh Falsafi; Mehrnaz Tahmasebi Arashlo; Saied Rajabalian; Sayed Amir Hossein Gandjalikhan Nassab
Journal:  J Dent (Shiraz)       Date:  2016-09

Review 8.  Anti-Inflammatory Drugs as Anticancer Agents.

Authors:  Silvia Zappavigna; Alessia Maria Cossu; Anna Grimaldi; Marco Bocchetti; Giuseppe Andrea Ferraro; Giovanni Francesco Nicoletti; Rosanna Filosa; Michele Caraglia
Journal:  Int J Mol Sci       Date:  2020-04-09       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.